Assessment of Stroke Volume in Shock Using Echocardiography Versus Bioreactive Impedance
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
This study aims to evaluate the correlation between stroke volume measurements obtained by transthoracic echocardiography and bioreactance-based noninvasive cardiac output monitoring. The primary objective is to assess the level of agreement between these two modalities in critically ill patients.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:
• Age ≥ 18 years
• Clinical diagnosis of shock as determined by the treating ICU physician (e.g., hypotension requiring vasopressors or evidence of end-organ hypoperfusion)
• Able to obtain informed consent from the patient or a legally authorized representative
• Enrollment within 24 hours of ICU admission
Locations
United States
Nevada
University Medical Center Southern Nevada
RECRUITING
Las Vegas
Contact Information
Primary
Mutsumi J Kioka, Medical Doctor
mutsumi.kioka@unlv.edu
7026712345
Backup
Office of Research Integrity Human Subjects UNLV
IRB@unlv.edu
7028952794
Time Frame
Start Date: 2024-10-19
Estimated Completion Date: 2026-09-01
Participants
Target number of participants: 100
Treatments
Shock Patients
This cohort includes adult patients presenting with clinical signs of shock in the intensive care unit. Each participant will undergo stroke volume measurement using both transthoracic echocardiography and bioreactance-based monitoring (Cheetah NICOM) before and after passive leg raising. No therapeutic intervention will be performed as part of the study.
Related Therapeutic Areas
Sponsors
Leads: University of Nevada, Las Vegas